Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Garrett

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|September 23, 2017
PD-L1 is an activation-independent marker of brown adipocytesJessica R Ingram, Michael Dougan, Mohammad Rashidian, et al.
Science Translational Medicine|October 26, 2018
Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastomaLei Huang, Sarah Garrett Injac, Kemi Cui, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Design of High Affinity Binders to Convex Protein Target SitesWei Yang, Derrick R Hicks, Agnidipta Ghosh, et al.
Nature Communications|February 26, 2025
Design of high-affinity binders to immune modulating receptors for cancer immunotherapyWei Yang, Derrick R Hicks, Agnidipta Ghosh, et al.
Annals of the New York Academy of Sciences|August 20, 2021
Metabolic decisions in development and disease-a Keystone Symposia reportJennifer Cable, Olivier Pourquié, Kathryn E Wellen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|September 23, 2017
PD-L1 is an activation-independent marker of brown adipocytesJessica R Ingram, Michael Dougan, Mohammad Rashidian, et al.
Science Translational Medicine|October 26, 2018
Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastomaLei Huang, Sarah Garrett Injac, Kemi Cui, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Design of High Affinity Binders to Convex Protein Target SitesWei Yang, Derrick R Hicks, Agnidipta Ghosh, et al.
Nature Communications|February 26, 2025
Design of high-affinity binders to immune modulating receptors for cancer immunotherapyWei Yang, Derrick R Hicks, Agnidipta Ghosh, et al.
Annals of the New York Academy of Sciences|August 20, 2021
Metabolic decisions in development and disease-a Keystone Symposia reportJennifer Cable, Olivier Pourquié, Kathryn E Wellen, et al.
Pageof 2